BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Deals

  APP Pharmaceuticals Announces Completion of Acquisition by Fresenius Kabi AG

  September 10, 2008

   · 

  1 min read
• Drug Development

  Sanofi-Aventis (France) New Study Results Support the “Basal Plus” Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes

  September 10, 2008

   · 

  6 min read
• Business

  Accenture Announces $550 Million, 10-year Agreement with Bristol-Myers Squibb Company

  September 10, 2008

   · 

  2 min read
• Pharm Country

  Mylan Inc. Prices $500 Million Cash Convertible Notes due 2015

  September 10, 2008

   · 

  4 min read
• Policy

  Shareholder Files Derivative Complaint against Management and Board Members of ARTES Medical Inc.

  September 10, 2008

   · 

  1 min read
• Biotech Bay

  Vermillion and Stanford University Scientists Receive ‘Best Research Award’ From the PAD Coalition

  September 10, 2008

   · 

  4 min read
• Biotech Bay

  Cerus Corporation to Present at the Baird Small Cap Health Care Conference

  September 10, 2008

   · 

  1 min read
• Business

  North American Scientific Inc. to Hold Conference Call and Webcast on Third Quarter Fiscal Year 2008 Financial Results on Thursday, September 11, 2008

  September 10, 2008

   · 

  1 min read
• Drug Development

  Circassia Limited Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology

  September 10, 2008

   · 

  3 min read
• Bio NC

  Pozen, Inc. To Present at The UBS Warburg Life Sciences Conference

  September 10, 2008

   · 

  1 min read